Hỗ trợ : vitricongty.com@gmail.com

Pfizer & Co., Inc. 25 Lượt xem

Pfizer & Co., Inc.

25 Lượt xem
Giới thiệu về Công ty

New ‘discreet’ Viagra Launched ending Embarrassment Of Blue Pill

The makers of Viagra are set to launch a brand-new ‘discrete’ form of the drug that will change the iconic – and instantly recognisable – little blue pill.

The distinctive diamond-shaped tablets could soon be replaced by a pink, rectangular ‘wafer’ that liquifies on the tongue, implying it does not need to be taken with water.

About half of males over 40 suffer erectile dysfunction in the UK and in 2015 there was a record 4.57 million prescriptions for Viagra on the NHS.

The drug first concerned the market in the 1990s after being invented by the American pharmaceutical business Pfizer.

It was very first established in the 1980s as a heart illness medication, but trial individuals discovered it had an unusual adverse effects – frequent erections.

Now, Pfizer spin-off Viatris, which owns the Viagra name and brand, has actually made an application for a trademark in the UK for the new kind of the drug, Viagra ODF.

Viatris has already released the Viagra ODF in Canada and marketed it as being ‘thin and discreet’ which may be more suitable for many consumers.

The unique tablets – which can cause embarrassment for some clients – has actually been reinvented and a new dissolvable type may be offered to Brits in the next five years. Stock image

‘Tablets are not always tolerable to clients and likewise sometimes the size of tablets may put clients off having them,’ Thorrun Govind, pharmacist and health specialist, told The Telegraph.

She added: ‘Some men may still be discovering the principle of having Viagr embarrassing, however I would hope that guys’s health and conversations about sexual health have actually moved on considering that Viagra was very first formulated.’

Ms Govind thinks this brand-new design is a ‘positive step forward’.

The new dissolvable medication is believed to most likely concerned the UK imminently.

Rebecca Anderson-Smith, partner and chartered trade mark lawyer at Mewburn Ellis, told the paper that the hallmark application is a ‘good sign’ it will be readily available within the next five years.

She described trade mark registrations can be cancelled if they are not used for a continuous duration of 5 years or more after registration. As a result, it appears Viatris intends to introduce the item within the next couple of years.

However, granting a hallmark would not ensure the ODF might be offered and it would need to be authorized by the Medicines & Healthcare products Regulatory Agency initially.

It’s anticipated to cost the same as the tablet version and to be available in the same doses.

A total of 4.57 million prescriptions for sildenafil, more typically known by the trademark name Viagra, and other kinds of impotency drugs offered under the brand name names Cialis and Levitra, were dished out by the health service in 2023

This comes after dodgy Viagra was found to be Britain’s most significant counterfeit drug after more than ₤ 6.2 million of fake blue pill were seized by UK regulators in 2023.

More supplies of the erectile dysfunction drug were discovered than knock-off variations of painkillers like morphine.

Health authorities said online merchants flouting guidelines were behind the counterfeit products with the majority of being imported from nations like India without an appropriate licence.

Data, from UK regulator The Medicines and Healthcare items Regulatory Agency (MHRA), reveal 2.6 million doses of sildenafil, the generic name for the medication best understood as Viagra, were confiscated in 2015.

Another half-million doses of tadalafil, another erectile dysfunction drug offered under the brand Cialis worth ₤ 1.2 million were likewise seized.

While all medications bring possible adverse effects drugs from undependable sources might either not work or carry ingredients or impurities like heavy metals or other drugs that might be harmful.

Công ty này không có công việc tích cực

Liên hệ chúng tôi

Về chúng tôi

Đăng ký nhận bản tin từ chúng tôi